ATE407130T1 - Verfahren zur herstellung von 2- azetidinonderivaten - Google Patents

Verfahren zur herstellung von 2- azetidinonderivaten

Info

Publication number
ATE407130T1
ATE407130T1 AT02705071T AT02705071T ATE407130T1 AT E407130 T1 ATE407130 T1 AT E407130T1 AT 02705071 T AT02705071 T AT 02705071T AT 02705071 T AT02705071 T AT 02705071T AT E407130 T1 ATE407130 T1 AT E407130T1
Authority
AT
Austria
Prior art keywords
producing
following formula
compound represented
azetidinone derivatives
azetidinone
Prior art date
Application number
AT02705071T
Other languages
English (en)
Inventor
Kouji Sato
Tsutomu Yagi
Yutaka Kitagawa
Shigeru Ichikawa
Akihiro Imura
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Application granted granted Critical
Publication of ATE407130T1 publication Critical patent/ATE407130T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
AT02705071T 2001-03-07 2002-03-04 Verfahren zur herstellung von 2- azetidinonderivaten ATE407130T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001063840 2001-03-07

Publications (1)

Publication Number Publication Date
ATE407130T1 true ATE407130T1 (de) 2008-09-15

Family

ID=18922762

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02705071T ATE407130T1 (de) 2001-03-07 2002-03-04 Verfahren zur herstellung von 2- azetidinonderivaten

Country Status (12)

Country Link
US (1) US7126003B2 (de)
EP (1) EP1375495B1 (de)
JP (1) JP4142444B2 (de)
KR (1) KR100851515B1 (de)
CN (1) CN1266148C (de)
AT (1) ATE407130T1 (de)
DE (1) DE50212728D1 (de)
ES (1) ES2311591T3 (de)
MY (1) MY139322A (de)
NO (1) NO20033917L (de)
TW (1) TWI311135B (de)
WO (1) WO2002070512A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003045953A1 (en) 2001-11-29 2003-06-05 Daiichi Pharmaceutical Co., Ltd. Crystals of taxane derivative and process for their production
MX2007003318A (es) 2004-09-20 2007-05-18 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
US8071603B2 (en) 2004-09-20 2011-12-06 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
MX2007003319A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
CN101084212A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为硬脂酰CoA去饱和酶介导剂的用途
CA2580855A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
CA2580857A1 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
TW200626138A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
EP2029138A1 (de) 2005-06-03 2009-03-04 Xenon Pharmaceuticals Inc. Aminothiazolderivate als humane stearoyl-coa desaturasehemmer
CN100494204C (zh) * 2006-01-12 2009-06-03 上海交通大学 (1’r,3r,4r)-4-乙酸基-3-(1-叔丁基二甲基硅氧基乙基)氮杂环丁烷-2-酮的氧化合成方法
US8785669B2 (en) 2010-06-30 2014-07-22 Gfv, Llc Taxane compounds, compositions and methods
US8697892B2 (en) 2010-06-30 2014-04-15 Gfv, Llc Taxane compounds, compositions and methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0679559B2 (ja) * 1985-06-06 1994-10-12 三共株式会社 光学活性アゼチジノン誘導体の製法
EP1001036B1 (de) * 1992-01-15 2004-10-20 E.R. Squibb & Sons, Inc. Enzymatische Verfahren zur Aüftrennüng von Enantiomeren-Mischungen nützlich als Zwischenprodukte zur Herstellung von Taxanen
FR2688499B1 (fr) 1992-03-10 1994-05-06 Rhone Poulenc Rorer Sa Procede de preparation de la beta-phenylisoserine et de ses analogues.
EP0582469A2 (de) 1992-08-06 1994-02-09 Wisconsin Alumni Research Foundation Verfahren zur Herstellung von Taxol-Typ-Verbindungen vom Beta-Laktam-Vorläufer
TW397866B (en) * 1993-07-14 2000-07-11 Bristol Myers Squibb Co Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes
JP3703519B2 (ja) 1994-05-31 2005-10-05 株式会社クラレ 光学活性体の製造方法
JP2779386B2 (ja) 1995-11-01 1998-07-23 株式会社カンキョー 全熱交換換気装置
DE19605024A1 (de) 1996-01-31 1997-08-07 Schering Ag Neue selektive Taxane, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
EP0933360A1 (de) 1997-12-22 1999-08-04 Pharmachemie B.V. Synthese von Beta-lactamen
US6677456B2 (en) * 1999-10-15 2004-01-13 Daiichi Pharmaceutical Co., Ltd. Pentacyclic taxan compound
US6548293B1 (en) * 1999-10-18 2003-04-15 Fsu Research Foundation, Inc. Enzymatic process for the resolution of enantiomeric mixtures of β-lactams

Also Published As

Publication number Publication date
KR100851515B1 (ko) 2008-08-11
CN1266148C (zh) 2006-07-26
US20040072309A1 (en) 2004-04-15
EP1375495A1 (de) 2004-01-02
TWI311135B (en) 2009-06-21
CN1507443A (zh) 2004-06-23
JPWO2002070512A1 (ja) 2004-07-02
DE50212728D1 (de) 2008-10-16
WO2002070512A1 (en) 2002-09-12
NO20033917D0 (no) 2003-09-04
EP1375495A4 (de) 2005-03-09
ES2311591T3 (es) 2009-02-16
MY139322A (en) 2009-09-30
KR20030080072A (ko) 2003-10-10
EP1375495B1 (de) 2008-09-03
HK1058668A1 (en) 2004-05-28
JP4142444B2 (ja) 2008-09-03
US7126003B2 (en) 2006-10-24
NO20033917L (no) 2003-10-31

Similar Documents

Publication Publication Date Title
ATE506356T1 (de) Verfahren zur herstellung von 3-halo-4,5-dihydro- 1h-pyrazolen
ATE497013T1 (de) Verfahren zur herstellung von glutaminsäurederivaten
DE69915004D1 (de) 5-Oxo-pyrrolidine-2-Carbonsäure-Hydroxamidderivate
ATE407130T1 (de) Verfahren zur herstellung von 2- azetidinonderivaten
ATE519747T1 (de) Verfahren zur herstellung von cyclopentaägüchinazolin-derivaten
ATE442363T1 (de) Verfahren zur herstellung von pyridinverbindungen
ATE355263T1 (de) Verfahren zur herstellung von(4e)-5-chloro-2- isopropyl-4-pentensäureester und optischaktivem isomer davon
EP1484322A4 (de) Verfahren zur herstellung eines optisch aktiven sulfoxid derivats
DE69218414D1 (de) Verfahren zur herstellung von trans-piperidin-2,5-dicarboxylaten
ATE439333T1 (de) Verfahren zur herstellung optisch aktiver propoxyanilinderivate
ATE399152T1 (de) Verfahren zur herstellung von optisch aktiven azetidin-2-carbonsäuren
DE60214283D1 (de) Fructosyl-Transferase produzierender Mikroorganismus und Verfahren zur Herstellung von Fructooligosacchariden und Neofructooligosacchariden unter dessen Verwendung
ATE229000T1 (de) Verfahren zur herstellung von alpha-aminoketonen
DE60133395D1 (de) Verfahren zur herstellung von alpha'-chlorketonen
DE69814771D1 (de) Gamma-oxohomophenylalanin derivate und ein verfahren zur herstellung von homophenylalanin derivaten durch reduktion derselben
ATE205178T1 (de) Verfahren zur herstellung von 3,4-dihydroxy-3- cyclobuten-1,2-dion
ATE555075T1 (de) Verfahren zur herstellung von formylcyclopropancarbonsäureestern
ATE244228T1 (de) Verfahren zur herstellung von chloroacetylaminothiazoleaceticsäure derivate
DE60028998D1 (de) Verfahren zur herstellung einer benzylamin-verbindung
ATE200290T1 (de) Verfahren zur herstellung von indolocarbazol- derivaten
ATE248841T1 (de) Verfahren zur herstellung von penicilling- phenylester
ATE248796T1 (de) Verfahren zur herstellung von alpha- halogenketonen
DE50213141D1 (de) Verfahren zur Herstellung von Glycinderivaten
DE60035925D1 (de) Verfahren zur Herstellung von Cephalosporin-Derivaten
ATE444966T1 (de) Verfahren zur herstellung von 3-glutamid gallensäurederivaten durch verwendung von n- geschützten methyl-pyroglutamat

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee